Dr. Hoppe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Childrens Hospital Colorado
13123 E 16TH Ave B395
Aurora, CO 80045Phone+1 720-777-6181Fax+1 720-777-7284
Education & Training
- University of ColoradoFellowship, Pediatric Pulmonology, 2012 - 2015
- University of ColoradoResidency, Pediatrics, 2009 - 2012
- Rutgers Robert Wood Johnson Medical SchoolClass of 2009
Certifications & Licensure
- CO State Medical License 2012 - 2025
- WY State Medical License 2023 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary Exacerbation Start of enrollment: 2014 Aug 01
- Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis Start of enrollment: 2022 Jul 29
Roles: Principal Investigator, Contact
- Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography Start of enrollment: 2022 Aug 01
Roles: Contact
Publications & Presentations
PubMed
- 23 citationsLong-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, ...Jordana E. Hoppe, Mark A. Chilvers, Felix Ratjen, John McNamara, Caroline A. Owen
The Lancet. Respiratory Medicine. 2021-05-06 - 42 citationsPhase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least OneAllele.Jennifer L Goralski, Jordana E Hoppe, Marcus A Mall, Susanna A McColley, Edward McKone
American Journal of Respiratory and Critical Care Medicine. 2023-07-01 - 12 citationsCharacteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosisJordana E. Hoppe, Brandie D. Wagner, Frank J. Accurso, Edith T. Zemanick, Scott D. Sagel
Journal of Cystic Fibrosis. 2018-11-01
Press Mentions
- New Cystic Fibrosis Research Gives Local Family HopeMay 27th, 2021
- Orkambi Shows Long-Term Safety, Efficacy in Children Ages 2-5May 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: